Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome.

Novelli S, García-Muret P, Mozos A, Sierra J, Briones J.

Leuk Lymphoma. 2016 May;57(5):1060-6. doi: 10.3109/10428194.2015.1057894. Epub 2016 Jan 11.

PMID:
27096891
2.

Alemtuzumab treatment for Sézary syndrome: A single-center experience.

Novelli S, García-Muret P, Sierra J, Briones J.

J Dermatolog Treat. 2016;27(2):179-81. doi: 10.3109/09546634.2015.1086479. Epub 2015 Sep 25.

PMID:
26329989
3.

Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.

Muniesa C, Estrach T, Pujol RM, Gallardo F, Garcia-Muret P, Climent J, Servitje O.

J Am Acad Dermatol. 2010 Mar;62(3):418-26. doi: 10.1016/j.jaad.2009.03.014. Epub 2010 Jan 15.

PMID:
20079954
4.

Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.

Giménez S, Costa C, Espinet B, Solé F, Pujol RM, Puigdecanet E, García-Moreno P, Sánchez J, Gallardo F, Estrach T, García-Muret P, Romagosa V, Serrano S, Servitje O.

Exp Dermatol. 2005 Dec;14(12):883-90.

PMID:
16274455
5.

Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.

Espinet B, Salido M, Pujol RM, Florensa L, Gallardo F, Domingo A, Servitje O, Estrach T, Garcìa-Muret P, Woessner S, Serrano S, Solé F.

Haematologica. 2004 Feb;89(2):165-73.

Supplemental Content

Loading ...
Support Center